ANAB – anaptysbio, inc. (US:NASDAQ)
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors [Yahoo! Finance]
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Johnson Rice.
Anaptys Announces Stock Repurchase Plan
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com